- Published at
- by manilatimes.net
mixed
mixed
News for ObsEva SA (OBSV)
- Published at
- by globenewswire.com
positivepositiveObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 3, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...- Published at
- by globenewswire.com
positivepositiveObsEva Announces Update on Board of Directors
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...- Published at
- by globenewswire.com
mixedmixedXOMA Reports Fourth Quarter and Full Year 2023 Financial
Raised up to $140 million of non-dilutive non-recourse capital through a royalty-backed loan related to VABYSMO® from funds managed by Blue Owl Capital ...- Published at
- by marketscreener.com
positivepositiveObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 28 February 2024 – ObsEva SA , a biopharmaceutical company developing novel therapies for women's...- Published at
- by globenewswire.com
positivepositiveObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 28 February 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...- Published at
- by globenewswire.com
positivepositiveGeneva Court Grants Temporary Moratorium to ObsEva
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – 31 January 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical...- Published at
- by globenewswire.com
positivepositiveObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – November 30, 2023 – ObsEva SA (SIX: OBSN), a...- Published at
- by globenewswire.com
positivepositiveXOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value
Received $6.6 million in cash receipts during the quarter related to our growing royalty base and certain development milestones One New Drug...- Published at
- by marketscreener.com
positivepositiveOrganon Returns Ebopiprant to XOMA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – October 27, 2023 – ObsEva SA , a biopharmaceutical company developing novel therapies for...- Published at
- by markets.businessinsider.com
positivepositiveOrganon Returns Ebopiprant to XOMA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – October 27, 2023 – ObsEva SA (SIX: OBSN), a biopharmace...- Published at
- by globenewswire.com
positivepositiveOrganon Returns Ebopiprant to XOMA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – October 27, 2023 – ObsEva SA (SIX: OBSN), a...- Published at
- by prnewswire.com
mixedmixedEndometriosis Drugs Global Market Report 2023: Emerging Treatments for Endometriosis & Endometrial Cancer Present Opportunities
/PRNewswire/ -- The- Published at
- by investing.com
mixedmixedU.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.17% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.17%OBSVN.MXOBSVOBSN.SWMCAEUMCAERMCAEMCACUMCACRKALAILU.DEILMN.MXILMNI1LM34.SADOW1.MXD1OW34.SAAPC.DEALGN.MXALGNAAPLD.BAAAPLCL.SNAAPLC.BAAAPL.SNAAPL.NEAAPL.MXAAPL.BAAAPLA1LG34.SA0JQ2.L0J8Z.L0HCK.LVZ.SNVZ.MXVZ.BAVZVERZ34.SADOWBAC.DE2OY.DEVERUSECOPRAXLUMN.MXLUMNKOD.BAKOCL.SNKOC.BAHRLHO7.DECOSTCL.SNCOSTBACL.SN0J5Z.L0HVP.L- Published at
- by benzinga.com
mixedmixedObsEva, Ensysce Biosciences And 2 Other Stocks Under $1 Insiders Are Aggressively Buying - CLS Holdings USA (OTC:CLSH), BrightRock Gold (OTC:BRGC)
The Dow Jones jumped by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.- Published at
- by benzinga.com
mixedmixedWhy Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket - AMC Entertainment (NYSE:AMC), Bilibili (NASDAQ:BILI)
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.- Published at
- by investing.com
mixedmixedU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.02% By Investing.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.02%- Published at
- by gurufocus.com
positivepositiveNew Leaf Venture Partners, L.L.C.'s Top 5 Sells of the 4th Quarter
GuruFocus Article or News written by insider and the topic is about:- Published at
- by gurufocus.com
positivepositiveMedicxi Ventures Management (Jersey) Ltd Buys 3, Sells 2 in 4th Quarter
GuruFocus Article or News written by insider and the topic is about:- Published at
- by benzinga.com
mixedmixedWhy Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session - Arcellx (NASDAQ:ACLX), Agrify (NASDAQ:AGFY)
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.YQVKTXTRKATERNSNPXDSNPXSMMTSLNOSCPSRLAYRDIBRDIQUMUPRFXPHIPHGE.TAPHGE-WTPHGE-UNPHGENHMLCOMDGLIVCIPDNIHICPT.MXICPTHZNFWPFTFTCOEPCELCCEIAXLAASPUARBKFARB.LAPZ.AXAPPHWAPPHANTEANEBAMC.MXAMCAKROA2MC34.SA0VQA.L0A8H.LTMCTELLSEERRELLNUPMFNUAG.TONEXA.TONEXANEWPMRSNGOSSETNBCZOOCVNACHPT-WTCHPTCCCCARDXALT1.MXALTAGFY0LE3.L0A79.L0A4C.LZZA.DEVTGNOTICOBSVN.MXOBSVOBSN.SWNEPT.TONEPTMSCL.SNIPHYFIPHAIPH.PAGEVO.MXGEVODOMOCNK.MXCNKCEREWCERE0A41.L